Foster & Motley’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.23M | Sell |
4,535
-107
| -2% | -$58.1K | 0.12% | 160 |
|
|
2025
Q4 | $2.69M | Sell |
4,642
-279
| -6% | -$158K | 0.14% | 145 |
|
|
2025
Q3 | $2.39M | Sell |
4,921
-235
| -5% | -$109K | 0.13% | 151 |
|
|
2025
Q2 | $2.09M | Sell |
5,156
-293
| -5% | -$123K | 0.12% | 160 |
|
|
2025
Q1 | $2.71M | Sell |
5,449
-240
| -4% | -$130K | 0.17% | 132 |
|
|
2024
Q4 | $2.96M | Sell |
5,689
-282
| -5% | -$155K | 0.19% | 118 |
|
|
2024
Q3 | $3.69M | Buy |
5,971
+141
| +2% | +$83.5K | 0.23% | 108 |
|
|
2024
Q2 | $3.22M | Sell |
5,830
-389
| -6% | -$223K | 0.22% | 116 |
|
|
2024
Q1 | $3.62M | Sell |
6,219
-546
| -8% | -$306K | 0.25% | 111 |
|
|
2023
Q4 | $3.59M | Sell |
6,765
-689
| -9% | -$333K | 0.27% | 107 |
|
|
2023
Q3 | $3.77M | Sell |
7,454
-330
| -4% | -$176K | 0.31% | 90 |
|
|
2023
Q2 | $4.06M | Buy |
7,784
+283
| +4% | +$153K | 0.31% | 88 |
|
|
2023
Q1 | $4.32M | Sell |
7,501
-215
| -3% | -$121K | 0.35% | 74 |
|
|
2022
Q4 | $4.25M | Sell |
7,716
-97
| -1% | -$51.4K | 0.36% | 73 |
|
|
2022
Q3 | $3.96M | Sell |
7,813
-90
| -1% | -$50.4K | 0.38% | 63 |
|
|
2022
Q2 | $4.29M | Sell |
7,903
-224
| -3% | -$123K | 0.38% | 63 |
|
|
2022
Q1 | $4.8M | Sell |
8,127
-239
| -3% | -$137K | 0.38% | 68 |
|
|
2021
Q4 | $5.58M | Buy |
8,366
+50
| +0.6% | +$31.2K | 0.43% | 60 |
|
|
2021
Q3 | $4.75M | Sell |
8,316
-403
| -5% | -$221K | 0.4% | 65 |
|
|
2021
Q2 | $4.4M | Sell |
8,719
-195
| -2% | -$92K | 0.37% | 70 |
|
|
2021
Q1 | $4.07M | Sell |
8,914
-410
| -4% | -$196K | 0.34% | 74 |
|
|
2020
Q4 | $4.34M | Sell |
9,324
-122
| -1% | -$57.2K | 0.42% | 67 |
|
|
2020
Q3 | $4.17M | Sell |
9,446
-552
| -6% | -$228K | 0.49% | 57 |
|
|
2020
Q2 | $3.62M | Sell |
9,998
-1,150
| -10% | -$385K | 0.45% | 62 |
|
|
2020
Q1 | $3.16M | Sell |
11,148
-510
| -4% | -$161K | 0.47% | 58 |
|
|
2019
Q4 | $3.79M | Sell |
11,658
-702
| -6% | -$213K | 0.47% | 58 |
|
|
2019
Q3 | $3.6M | Sell |
12,360
-219
| -2% | -$62.7K | 0.49% | 55 |
|
|
2019
Q2 | $3.69M | Sell |
12,579
-40
| -0.3% | -$11K | 0.52% | 58 |
|
|
2019
Q1 | $3.45M | Sell |
12,619
-790
| -6% | -$197K | 0.5% | 58 |
|
|
2018
Q4 | $3M | Sell |
13,409
-313
| -2% | -$73.4K | 0.48% | 65 |
|
|
2018
Q3 | $3.35M | Sell |
13,722
-1,741
| -11% | -$401K | 0.5% | 61 |
|
|
2018
Q2 | $3.2M | Sell |
15,463
-75
| -0.5% | -$15.9K | 0.51% | 60 |
|
|
2018
Q1 | $3.21M | Sell |
15,538
-2,489
| -14% | -$522K | 0.52% | 55 |
|
|
2017
Q4 | $3.42M | Sell |
18,027
-965
| -5% | -$185K | 0.55% | 57 |
|
|
2017
Q3 | $3.59M | Sell |
18,992
-1,660
| -8% | -$301K | 0.62% | 52 |
|
|
2017
Q2 | $3.6M | Sell |
20,652
-1,293
| -6% | -$217K | 0.64% | 53 |
|
|
2017
Q1 | $3.37M | Buy |
21,945
+1,074
| +5% | +$164K | 0.61% | 56 |
|
|
2016
Q4 | $2.94M | Buy |
20,871
+44
| +0.2% | +$6.49K | 0.56% | 64 |
|
|
2016
Q3 | $3.31M | Buy |
20,827
+272
| +1% | +$41.9K | 0.64% | 60 |
|
|
2016
Q2 | $3.04M | Buy |
20,555
+1,856
| +10% | +$274K | 0.6% | 67 |
|
|
2016
Q1 | $2.65M | Buy |
18,699
+179
| +1% | +$24K | 0.54% | 70 |
|
|
2015
Q4 | $2.63M | Sell |
18,520
-1,513
| -8% | -$202K | 0.56% | 66 |
|
|
2015
Q3 | $2.45M | Sell |
20,033
-2,961
| -13% | -$386K | 0.56% | 65 |
|
|
2015
Q2 | $2.98M | Sell |
22,994
-9,698
| -30% | -$1.26M | 0.65% | 56 |
|
|
2015
Q1 | $4.39M | Sell |
32,692
-12,278
| -27% | -$1.58M | 0.96% | 38 |
|
|
2014
Q4 | $5.63M | Sell |
44,970
-5,042
| -10% | -$613K | 1.28% | 24 |
|
|
2014
Q3 | $6.09M | Buy |
50,012
+1,437
| +3% | +$175K | 1.41% | 27 |
|
|
2014
Q2 | $5.73M | Buy |
48,575
+1,047
| +2% | +$123K | 1.32% | 27 |
|
|
2014
Q1 | $5.71M | Sell |
47,528
-2,526
| -5% | -$300K | 1.4% | 24 |
|
|
2013
Q4 | $5.57M | Sell |
50,054
-3,516
| -7% | -$350K | 1.41% | 24 |
|
|
2013
Q3 | $4.94M | Sell |
53,570
-999
| -2% | -$90.3K | 1.32% | 30 |
|
|
2013
Q2 | $4.62M | Buy |
+54,569
| New | +$4.54M | 1.28% | 33 |
|
Other funds holding TMO
VCM
Foster & Motley's TMO Position: Q1 2026 in Review
Foster & Motley reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q1 2026, selling an estimated $58.1K and leaving 4,535 shares worth $2.23M. The position accounts for 0.12% of the portfolio, ranked #160.
Foster & Motley first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.09M in Q3 2014. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Foster & Motley held 4,535 shares of Thermo Fisher Scientific worth $2.23M as of Q1 2026.
- Foster & Motley sold 107 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.1K.
- Thermo Fisher Scientific made up 0.12% of Foster & Motley's portfolio in Q1 2026, its #160 holding.
- Foster & Motley first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Foster & Motley's Thermo Fisher Scientific position peaked at $6.09M in Q3 2014.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.